| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102299
Status
Published
Date of creation
2011-09-14 11:48 UTC (guygeraldmboma@yahoo.fr)
Date of publication
2011-09-14 11:48 UTC (guygeraldmboma@yahoo.fr)

This document is also available in the following languages:
Origin of report
Country
  • Democratic Republic of the Congo
Contact officer for report
Coordinates
M. Vincent KASULU SEYA MAKONGA
Directeur de Développement Durable
Ministère de l'Environnement, Conservation de la Nature et Tourisme (MECNT)
15, Av. Papa ILEO, Kinshasa/Gombe
Kinshasa, Kinshasa
Democratic Republic of the Congo, B.P. 12348 Kinshasa I
Phone:+243 999905957 / 814510594
Email:kaseyamak@yahoo.fr
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
• Ministère de l'Agriculture, Pêche et Elevage (Bureau de la Surveillance Phytosanitaire et Service National des Semences - SENASEM);
• Ministère du Commerce, Petites et Moyennes Entreprises;
• Direction Générale  des Douanes et Accises (DGDA)
• Centre National d'Information sur l'Environnement (CNIE);
• Office Congolais de Contrôle (OCC);
• Laboratoire de Biotechnologie du Commissariat Général à l'Energie Atomique - Centre Régional d'Etude Nucléaire de Kinshasa (CGEA/CREN-K);
• Cellule Juridique du Ministère de l'Environnement;
• Direction de Développement Durable (DDD);
• Institut National d'Etude et Recherche Agronomiques (INERA);
• Réseau des Communicateurs en Environnement (RCN);
Submission
10. Date of submission
2011-09-14
11. Time period covered by this report
Start date
2007-08-16
Time period covered by this report
End date
2011-08-15
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is partially in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 5
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country:
FR
En ses articles 53 et 202 point 36.m, la Constitution de la RD Congo du 16 février 2006 tout comme la Loi du 09 juillet portant principes fondamentaux relatifs à la protection de l'environnement, en ses articles 62 et 63 jettent d'ores et déjà les bases d'une législation sur la gestion des risques biotechnologiques ainsi que sur l'utilisation de la biotechnologie.
Par ailleurs, d'autres textes juridiques de portée générale réglementent indirectement les organismes vivants modifiés. Il s'agit notamment de:
- la législation sur l'exercice du commerce (loi n°73-009 du 05 janvier 1973 telle que modifiée et complétée à ce jour;
- la législation en matière des prix (décret-loi du 20 mars 1961;
- la législation sur les droits et taxes à l'importation et à l'exportation (loi n°04/015 du 16 juillet 2004 fixant la nomenclature des actes des actes générateurs des recettes administratives, judiciaires, domaniales et de participation ainsi que leurs modalités de perception);
- la législation sur la biodiversité (Code forestier).
Depuis novembre 2005, la RDC a informé le secrétariat des noms et coordonnées de son Point Focal pour le Protocole de Cartagena, ceux de l'Autorité Nationale Compétente ainsi que ceux du Correspondant national du Centre d'échange pour la prévention des risques biotechnologiques. Aussi le document du cadre national de biosécurité est disponible sur le centre d'échange. Parallèlement à cette démarche, la RD Congo se propose, conformément à son cadre national de biosécurité, de mettre en place les arrangement institutionnels devant déboucher à l'institutionnalisation d'un Comité consultatif national de biosécurité et d'un Comité scientifique et technique de biosécurité.
En ce qui concerne le personnel affecté de façon permanente aux fonctions liées à la prévention des risques biotechnologiques, le nouveau cadre organique du Secrétariat Général à l'Environnement et Conservation de la Nature, approuvé provisoirement par Arrêté n°CAB.MIN/MBB/SGA/GPFP/JSK/035/2009 du 20 mars 2009 de Monsieur le Ministre de la Fonction Publique, crée au sein de la Direction de Développement Durable, Autorité Nationale Compétente au titre du Protocole de Cartagena, un nouveau Bureau Biosécurité qui a pour mission d'assurer le suivi de la mise en œuvre des décisions et recommandations prises dans le cadre des Réunions des Parties au Protocole de Cartagena, la gestion du Centre d'échange national ainsi que le suivi de la mise en œuvre du cadre national de biosécurité.
Trois personnes sont affectées à temps plein audit Bureau au lieu de quatre tel que prévu par le cadre organique.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
FR
Les organismes vivants modifiés qui sont des produits pharmaceutiques ne font pas l'objet d'une  réglementation spécifique. Cependant, les articles 62 et 63 de la loi portant principes fondamentaux relatifs relatifs à la protection de l'environnement, traitant de tous les organismes vivants modifiés sans distinction aucune, jettent déjà les bases pour une législation spécifique des OVM qui sont des produits pharmaceutiques.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • No
26. Does your country regulate the contained use of LMOs?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
FR
La Loi n°11/009 du 09 juillet 2011 portant principes fondamentaux relatifs à la protection de l'environnement fait obligation, en son article 62 alinéa 2 à l'Autorité nationale compétente de n'autoriser les mouvements transfrontires, l'utilisation confinée, la dissémination volontaire ou la mise en marché d'un organisme génétiquement modifié ou son dérivé qu'après une évaluation préalable des risques. Cependant, la même loi susmentionnée stipule que les méthodes d'évaluation et de gestion de ces risques, ainsi que le processus de prise de décision y relative sont définies par une loi spécifique.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
FR
Le projet du cadre national de biosécurité prévoit au sujet de la procédure d'accord préalable en connaissance de cause une procédure de prise de décision fondée sur les dispositions même du Protocole de Cartagena à savoir: la notification ou saisine de l'Autorité nationale compétente, l'accusé de réception et la prise de décision précédée de l'évaluation des risques et l'identification des dispositions pour la gestion des risques.

En ce qui concerne la notification, le notifiant est tenu responsable de l'exactitude des informations fournies. La notification doit contenir au minimum les informations requises par l'annexe 1 du Protocole.

L'Autorité nationale Compétente de la Partie importatrice accuse réception de la notification dans un délai maximum de 90 jours.
L'Autorité nationale compétente prend la décision dans un délai de 270 jours à dater de la date de la réception de la notification.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • No
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • No
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • No
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
FR
Dans le cas des OVMs destinés à être utilisés directement pour l'alimentation humaine ou animale, ou à être transformés, le projet du cadre national de biosécurité prévoit une procédure conforme à l'article 11 du Protocole de Cartagena.

En outre, le projet du cadre national de biosécurité dispose que l'aide alimentaire contenant des OVM soit moulue avant d'être distribuée aux populations.
dans tous les cas, l'article 62 al 2 de la loi portant principes fondamentaux relatifs à la protection de l'environnement impose à l'Autorité nationale compétente l'évaluation préalable des risques avant toute décision.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
FR
A ce jour, la RD Congo n'a connu aucun cas de reconsidération de la décision.
Toutefois, le projet de loi relative à la sécurité en biotechnologie dispose que toute autorisation accordée peut être révoquée ou soumise à des conditions supplémentaires autres que celles déjà imposées, si l'Autorité nationale compétente obtient par la suite des éléments nouveaux d'information sur l'OVM indiquant qu'il existe un risque pour la santé humaine, animale ou l'environnement.
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
FR
Dans le cadre du Marché Commun pour l'Afrique de l'Est et Australe (COMESA) auquel la RD Congo est Partie, un énoncé des politiques et  des directives pour manipuler les cultures commerciales génétiquement modifiées, le commerce des OVM et l'aide alimentaire d'urgence contenant les OVM ont été développées.

En ce qui concerne de manière spécifique les cultures commerciales génétiquement modifiées, les politiques et lignes directrices ont pour objectifs de fournir aux Etats membres du COMESA un mécanisme d'évaluation régionale centralisée des OGM destinés à une culture commerciale et promouvoir les exigences harmonisées d'évaluation des risques selon des lignes directrices développées au niveau international pour les OVM.
Le champs d'application de ces politiques et directives sont l'évaluation centralisée risques à travers l'opérationnalisation des sous-comités régionaux d'évaluation des risques liés aux OVM dans les pays COMESA, l'évaluation des risques pour la santé humaine ou l'environnement ainsi que les considérations socio-économiques, culturelles ou autres réalisées en accord avec les cadres nationaux de biosécurité.

Les politiques et les directives COMESA reconnaissent dûment la souveraineté et l'existence de lois et des politiques nationales de biosécurité. Un comité d'experts (PoE) a été établi en tant que comité permanent de guidage des politiques au sein du COMESA pour les domaines liés aux biotechnologies et à la biosécurité. Il va directement mettre en œuvre les politiques et les directives COMESA.

Il faut toutefois préciser que lesdites politiques et directives ne sont pas encore entrées en vigueur.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • No
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • No
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Not applicable
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
FR
La loi n°11/009 du 09 juillet 2011 portant principes fondamentaux relatifs à la protection de l'environnement dispose à son article 63 que les méthodes d'évaluation et de gestion des risques biotechnologiques ainsi que le processus de prise de décision relatif aux mouvements transfrontières des organismes génétiquement modifiés sont définis par une loi spécifique.

En ce qui concerne les directives techniques nécessaires pour formaliser les mécanismes d'évaluation et de gestion des risques biotechnologiques, le projet du cadre national de biosécurité propose qu'elles soient élaborées et définies en prenant en compte la situation en matière de biotechnologie moderne et de biosécurité en RD Congo mais aussi des dispositions du Protocole de Cartagena, des directives d'autres pays et autres directives pertinentes.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • No
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • No
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • No
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • No
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes, to some extent
123. Here you may provide further details on the implementation of Article 19 in your country:
FR
A ce jour la RD Congo a désigné une seule Autorité nationale compétente à qui les missions suivantes ont été confiées:
  a) participer à l'échelle nationale et internationale à la prise des mesures politiques pour la protection de la santé et de l'environnement contre les risques liés à l'utilisation de la biotechnologie moderne;
b) veiller à la mise en œuvre du Protocole et de la législation nationale sur les mouvements intentionnels et transfrontaliers non intentionnels des OGM;
c) mettre en œuvre les recommandations du comité consultatif relatives à l'importation, le transit, l'utilisation en milieu confiné, la dissémination ou la vente des OGM ou de leurs dérivés;
d) suivre l'évolution des OGM partout dans le monde et lorsque l'un d'entre eux semble poser un risque à la santé ou l'environnement, interdire son passage sur le territoire national et prévenir le centre d'échange, les services des douanes et les fonctionnaires chargés du commerce extérieur;
e) mettre à la disposition du public, une base des données sur les OGM destinés à l'alimentation animale ou humaine.

Toutefois, le projet du cadre national de biosécurité a levé l'option de mettre en place plus d'une Autorité nationale désignée.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information not available
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information available but not in the BCH
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
FR
Dans le but de dynamiser les activités relatives au centre d'échange, la RD Congo vient de désigner un nouveau correspondant du centre d'échange et les utilisateurs nationaux autorisés ont été désignés.

En ce qui concerne les informations nationales à rendre disponibles via le centre d'échange en vertu de l'article 20, la RD Congo ne les fournit pas pour la simple raison qu'elles ne sont pas disponibles.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • No
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • No
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Not applicable
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Easy
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • No
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
FR
La RD Congo a bénéficie de l'appui du FEM pour développer son cadre national de biosécurité. Cette activité a commencé avant la période couverte par le présent rapport mais s'est poursuivie au cours de ladite période. Le FEM a également appuyé la RD Congo pour la création des capacités pour la participation efficace au centre d'échange pour la prévention des risques biotechnologiques Phase I et Phase II. Enfin, le FEM a aussi apporté son appui à la RD Congo dans l'élaboration du présent rapport.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes, to a limited extent
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
FR
La Loi n° 11/09 du 09 juillet portant principes fondamentaux relatifs à la protection de l'environnement traite dans sa section 5 des Organismes Génétiquement Modifiés.
A l'instar d'autres lois qui traitent des questions relatives à l'environnement, la loi susmentionnée réaffirme de façon générale, le principe de l'implication du public dans l'élaboration de la politique et dans la gestion de l'environnement, de la biodiversité et des forêts ainsi que le droit d'ester en justice pour la protection de l'environnement. Ainsi, les organisations non gouvernementales locales travaillant dans le domaine de la biosécurité sont toujours associées aux différentes rencontres, ateliers d'échange et autres activités organisés par le Ministère de l'Environnnement. 
Aussi, le cadre national de biosécurité prévoit la mise en place d'un comité consultatif national de biosécurité auquel le le public participe par ses représentants. L'Autorité nationale compétente a l'obligation d'informer le public sur toutes les données non confidentielles qui lui sont communiquées dans la cadre de la notification et ce dans des délais raisonnables et à différentes phases du processus de prise de décision. Le public a la possibilité de soumettre par écrit ou au cours d'une audience publique ou d'une enquête, toute observation, information, analyse ou option qu'il juge pertinente au regard du projet d'activités mettant en jeu des organismes vivants modifiés.                       
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • Yes
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
FR
Il est prévu que la RD Congo signe le Protocole supplémentaire de Nagoya-Kuala Lumpur sur la responsabilité et la réparation en marge de la 66ième session de l'Assemblée Générale des Nations Unies.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes, First report only
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
A ce jour, on ne peut pas affirmer que le Protocole de Cartagena sur la biosécurité est effectivement et complétement mis en œuvre en RD Congo. Certes, le projet sur le développement du Cadre national de biosécurité a permis de franchir une étape importante en ayant permis notamment l'élaboration du projet de loi sur la sécurité en biotechnologie, la définition des structures nationales de gestion de biosécurité et la réalisation d'un état des lieux rapide sur les capacités nationales en biosécurité.

En dépit de tout ce travail, très peu d'avancées ont été notées durant la période couverte par le présent rapport.

Le projet de loi sur la sécurité en biotechnologie n'a pas encore été promulgué et hormis l'Autorité nationale compétente, les structures nationales de gestion de biosécurité ne sont pas encore opérationnelles et les besoins en renforcement des capacités demeurent nombreux.
Plusieurs raisons sont à la base de ces situations, en particulier le manque des moyens financiers nécessaires au fonctionnement des structures nationales de biosécurité et au renforcement des capacités.

Toutefois, la promulgation de la loi n°11/009 du 09 juillet 2011 portant principes fondamentaux relatifs à la protection de l'environnement augure l'adoption rapide du projet de loi sur la sécurité en biotechnologie. En effet, les articles 62 et 63 de la loi du 09 juillet 2011, traitent en substance des questions relatives à la gestion des organismes génétiquement modifiés et revoient à la compétence d'une loi spécifique toutes les autres questions  y relatives.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • None
Here you may provide further details
FR
Faute des moyens et de cadre pour ces formations
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • No
Here you may provide further details
FR
Faute des moyens
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • No funds mobilized
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • No
Survey 9.b) Risk management
  • No
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Here you may provide further details
FR
Jusque là aucune notification n'a été soummise
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Here you may provide further details
FR
Faute des laboratoires bien équipés pour ce genre d'opérations
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • No
Survey 13.c) Monitor
  • No
Here you may provide further details
FR
Faute des moyens matériels et financiers
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • Yes
Here you may provide further details
FR
Dans certains texte légaux surtout dans le domaine de l'environnement
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • One or more
Here you may provide further details
FR
Parce que je n'ai pas tout le documents à maé disposition
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
FR
La loi sur les principes fondamentaux sur l'environnement, le projet de loi sur la biosécurité, le cadre national de biosécurité, code forestier....
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • No
Here you may provide further details
FR
Faute des laboratoires mieux équipés, je ne pense pas qu'on soit vraiment à mesure de le faire
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • One or more
Survey 19.b) Monitoring
  • One or more
Survey 19.c) Management / Control
  • One or more
Here you may provide further details
FR
Par manque d'informations fiables, je pense qu'il y a certainement des personnes qui ont suivi ces différentes formaions
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • No
Here you may provide further details
FR
Il y a des laboratoires dans certains centres de recherches mais qui ne sont vraiment pas faits pour ce fait
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • No
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • No
Survey 22.b) Effective
  • No
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • One or more
Here you may provide further details
FR
Dans le cadre des projets BCH 1 et 2 certains agents de douane ont été invités et ont suivi les formations organisées
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • One or more
Here you may provide further details
FR
Dans les centres de recherches que nous disposons, je pense qu'il y a certainement des gens qui ont reçu ces formations malgré que les laboratoires ne soient pas bien équipés
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • One or more
Here you may provide further details
FR
Faute des données fiables, mais il y a des laboratoires qui font des recherches dans ce domaine
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • One or more
Here you may provide further details
FR
IDEM
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
FR
La loi sur biosécurité qui est en cours d'examen au parlement et le cadre national de biosécurité
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
FR
La loi sur la biosécurité ci haut, le cadre national de biosécurité ainsi que la stratégie de sensibilisation du public qui est en cours d'élaboration
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
  • Forums
  • Public hearings
  • ateliers de sensibilisations, des groupes et ONG participent dans les prises des décisions
Here you may provide further details
FR
Etant donné que la loi n'est pas encore promulguée, il est très difficile d'indiquer avec certitude laquelle est la plus utilisée
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Here you may provide further details
FR
Les universités qui disposent des facultés des sciences, environnement et agronomiques prévoient des programmes dans ce domaine
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • None
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • No
Survey 35.b) Enforcement system
  • No
Here you may provide further details
FR
Avec cette traduction, la question n'est pas claire
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • One or more
Here you may provide further details
FR
IDEM
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • None
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • BCH Central Portal
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • None
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Here you may provide further details
FR
Mais le projet de sensibilisation est en cours d'élaboration et la loi sur la biosécurité en cours d'adoption au parlement le prévoit
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Here you may provide further details
FR
La stratégie est en cours d'élaboration
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • None